Olema Pharmaceuticals, Inc. Common Stock

OLMA XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

930M

Short interest (May 15)

13.3%

Borrow Fee

0.52%

↑ 21.5%

Available Shares

300K

↓ 36.8%

Price Chart

Company Overview

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001750284

Asset Type: CS

Market Data

Market Cap: $933,744,464

Employees: 137

Status: Active

Short Interest

Current Borrow Fee 0.52%

Range: 0.52% - 0.55%

Available Shares 300K

Range: 200K - 300K

Recent Changes

Fee Change: ↓ 4.0%

Available Change: ↓ 9.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime